Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of innovative therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The firm's pipeline includes investigational product candidates that affect heme biosynthesis and iron metabolism.
| Last: | $59.34 |
|---|---|
| Change Percent: | -2.4% |
| Open: | $60.54 |
| Close: | $60.80 |
| High: | $62.54 |
| Low: | $59 |
| Volume: | 105,695 |
| Last Trade Date Time: | 03/13/2026 12:45:01 pm |
| Market Cap: | $2,821,824,610 |
|---|---|
| Float: | 32,299,039 |
| Insiders Ownership: | 0.06% |
| Institutions: | 62 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.discmedicine.com |
| Country: | US |
| City: | Watertown |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Disc Medicine Inc. (NASDAQ: IRON).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.